A patient with type 2 diabetes presents with microalbuminuria, non-proliferative diabetic retinopathy, and dyslipidemia. Which nursing intervention is most important to prioritize in the management of this patient's diabetic complications?

C) Monitor blood pressure and ensure adherence to antihypertensive therapy.

A) Educate the patient on the importance of regular eye examinations.

B) Initiate a discussion about increasing physical activity levels.

C) Monitor blood pressure and ensure adherence to antihypertensive therapy.

D) Counsel the patient on reducing dietary carbohydrate intake.

A patient with type 2 diabetes presents with an elevated HbA1c of 9.2%, microalbuminuria, and signs of non-proliferative diabetic retinopathy. Considering these findings, which nursing intervention is most appropriate to prioritize in the patient's care plan to prevent further complications?

B) Educate the patient on the importance of adhering to antihypertensive and lipid-lowering medications.

A) Increase the patient's daily carbohydrate intake to stabilize blood sugar levels.

B) Educate the patient on the importance of adhering to antihypertensive and lipid-lowering medications.

C) Encourage the patient to perform high-impact exercises to enhance cardiovascular health.

D) Advise the patient to decrease fluid intake to reduce kidney workload.

A patient with hypertension and diabetes presents with increased fatigue, occasional dizziness, and mild peripheral edema. Blood pressure is 160/95 mmHg, and there is evidence of peripheral neuropathy. Given these findings, what is the priority nursing intervention?

B) Educate the patient on the importance of medication adherence and explore barriers to compliance.

A) Recommend the patient take his antihypertensive medication at night to reduce daytime dizziness.

B) Educate the patient on the importance of medication adherence and explore barriers to compliance.

C) Suggest a dietary modification to decrease sodium intake and address peripheral edema.

D) Advise the patient to increase physical activity to improve circulation and reduce neuropathy symptoms.

A patient with type 2 diabetes and hypertension presents with increased fatigue and occasional dizziness after taking antihypertensive medications. His blood pressure is 160/95 mmHg, and he admits to missing doses due to a busy schedule and concerns about side effects. What is the most appropriate nursing intervention to improve medication adherence and manage his symptoms?

C) Collaborate with the healthcare provider to adjust the medication schedule to fit his work routine and discuss potential side effects management.

A) Encourage the patient to take his medications only when he feels symptomatic.

B) Suggest the patient takes all missed doses at once to quickly achieve therapeutic levels.

C) Collaborate with the healthcare provider to adjust the medication schedule to fit his work routine and discuss potential side effects management.

D) Advise the patient to stop taking his antihypertensive medications until his symptoms resolve.

A patient with a history of hypertension and diabetes presents with increased dizziness upon standing, peripheral edema, and worsening glycemic control. Based on these clinical findings, which nursing intervention is most appropriate to prioritize?

B) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

A) Educate the patient on increasing his sodium intake to improve blood pressure stability.

B) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

C) Recommend the patient to increase his daily protein intake to manage microalbuminuria.

D) Suggest the patient perform balance exercises to improve coordination and prevent falls.

A patient with a history of hypertension, diabetes, and renal impairment is experiencing dizziness upon standing and increased peripheral edema. Recent laboratory tests indicate elevated HbA1c and serum creatinine levels. Which nursing intervention should take priority to address the patient's current clinical presentation?

B) Instruct the patient to rise slowly from sitting to standing positions.

A) Educate the patient on the importance of reducing dietary sodium intake.

B) Instruct the patient to rise slowly from sitting to standing positions.

C) Encourage the patient to increase fluid intake to prevent dehydration.

D) Schedule the patient for a follow-up with a dietitian to manage blood sugar levels.

A patient with type 2 diabetes and hypertension has been experiencing orthostatic hypotension, leg swelling, and deteriorating kidney function. The healthcare team has adjusted his antihypertensive medication and is considering introducing an SGLT2 inhibitor. Which nursing intervention is most critical in monitoring the effectiveness and safety of the new treatment plan?

C) Evaluate the patient's renal function tests and urine output.

A) Monitor the patient's blood pressure and heart rate regularly.

B) Assess the patient's adherence to dietary and exercise recommendations.

C) Evaluate the patient's renal function tests and urine output.

D) Educate the patient about potential side effects of the SGLT2 inhibitor.

A patient has been taking an SGLT2 inhibitor for three weeks and presents with increased urinary frequency and symptoms of mild dehydration. Which nursing intervention is most appropriate to address these symptoms while maintaining the therapeutic benefits of the medication?

B) Advise the patient to increase their fluid intake to prevent dehydration.

A) Encourage the patient to reduce their fluid intake to minimize urinary frequency.

B) Advise the patient to increase their fluid intake to prevent dehydration.

C) Suggest the patient take the medication at bedtime to reduce daytime urinary frequency.

D) Recommend the patient discontinue the medication until symptoms resolve.

A patient on SGLT2 inhibitors reports increased urinary frequency, mild dehydration symptoms, and unchanged proteinuria levels. What is the nursing priority intervention to address these concerns?

B) Educate the patient on increasing fluid intake to prevent dehydration

A) Increase the patient's antihypertensive medication dosage

B) Educate the patient on increasing fluid intake to prevent dehydration

C) Advise the patient to stop the SGLT2 inhibitor immediately

D) Suggest reducing dietary protein to address proteinuria

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin deficiency or resistance leads to impaired glucose uptake by cells, resulting in elevated blood glucose levels. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells causes insulin deficiency, while in Type 2, cells become resistant to insulin's effects.

• Secondary mechanism: Chronic hyperglycemia causes damage to blood vessels and nerves due to the accumulation of advanced glycation end products (AGEs), leading to microvascular complications like retinopathy, nephropathy, and neuropathy.

• Key complication: Persistent high blood sugar can also result in macrovascular complications, increasing the risk of cardiovascular diseases due to endothelial dysfunction and atherosclerosis.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and intermittent blurry vision

• Key symptoms: Frequent urination, excessive thirst, tingling in feet, occasional chest discomfort

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, random blood glucose 210 mg/dL

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to perform additional diagnostic tests to evaluate the extent of the patient's diabetic complications. A comprehensive metabolic panel revealed a significantly elevated HbA1c level of 9.2%, indicating poor long-term blood glucose control. A lipid panel showed elevated LDL cholesterol at 160 mg/dL and decreased HDL cholesterol at 35 mg/dL, suggesting suboptimal management of dyslipidemia. Urinalysis revealed microalbuminuria, a sign of early diabetic nephropathy, which reflects kidney damage likely due to prolonged hyperglycemia and hypertension. Furthermore, a retinal examination showed signs of non-proliferative diabetic retinopathy, including microaneurysms and cotton wool spots, which could explain the patient's intermittent blurry vision.

These diagnostic results confirm the progression of microvascular complications and underscore the importance of aggressive management of the patient's diabetes and associated conditions. The presence of microalbuminuria and retinopathy highlights the need for tighter glycemic and blood pressure control, potentially requiring adjustments to his current medication regimen. The lipid abnormalities suggest a need for more aggressive lipid-lowering therapy, possibly including a higher dose of atorvastatin or the addition of another lipid-lowering agent.

The healthcare team convenes to discuss a comprehensive treatment plan that addresses the patient's uncontrolled diabetes, hypertension, and hyperlipidemia. Educating the patient on lifestyle modifications, including dietary changes, regular exercise, and adherence to medication, is crucial. Additionally, considering the patient's occupation as a construction worker, discussions about potential limitations due to peripheral neuropathy and the importance of foot care are prioritized to prevent further complications. The team plans to monitor the patient's response closely and schedule follow-up appointments to reassess his condition and adapt the management plan as needed.

Section 2

Change in Patient Status:

Two weeks after implementing the revised treatment plan, the patient returns for a follow-up visit. During the consultation, he reports experiencing increased fatigue and occasional dizziness, particularly after taking his antihypertensive medications. Upon further questioning, he admits to missing several doses of his prescribed medications due to a demanding work schedule and concerns about side effects. A physical examination reveals mild peripheral edema and a blood pressure reading of 160/95 mmHg, indicating persistent hypertension. His weight remains stable, but there is evidence of decreased sensation in his feet upon monofilament testing, suggesting worsening peripheral neuropathy.

Laboratory tests reveal a slight improvement in his HbA1c level, now at 8.8%, indicating some benefit from the implemented changes, yet still far from the target. However, the lipid panel shows little progress, with LDL cholesterol reduced only marginally to 155 mg/dL and HDL remaining at 35 mg/dL. The presence of microalbuminuria persists, and additional renal function tests indicate a serum creatinine level of 1.3 mg/dL, hinting at the early stages of chronic kidney disease. The patient's retinal examination still shows non-proliferative diabetic retinopathy, with no significant changes since the last evaluation.

These findings suggest that while there has been some improvement in glycemic control, the patient's adherence to the treatment regimen is inconsistent, contributing to the ongoing management challenges. The healthcare team recognizes the need to address the patient's concerns regarding medication side effects and work commitments. They emphasize the importance of adherence and consider adjusting his medication schedule to better fit his lifestyle. Furthermore, they discuss the potential introduction of a combination therapy to manage his dyslipidemia more effectively and reassess his antihypertensive regimen to achieve better blood pressure control without undue side effects. Patient education is reinforced, focusing on the long-term benefits of strict adherence and lifestyle modifications to prevent further complications.

Section 3

Two weeks later, the patient returns for another follow-up appointment. This time, he reports experiencing more frequent episodes of dizziness, particularly when he stands up quickly, and has noted increased swelling in his legs. He also mentions having trouble with balance and coordination, which has led to a couple of near falls at work. Upon examination, the peripheral edema has progressed to moderate, extending above the ankles, and there is now a noticeable postural drop in blood pressure, with readings of 145/90 mmHg when sitting and 120/75 mmHg upon standing. These findings suggest orthostatic hypotension, likely exacerbated by his antihypertensive regimen and possible dehydration.

Laboratory tests show that his HbA1c level has slightly increased to 9.0%, indicating a decline in glycemic control. Renal function tests reveal a further increase in serum creatinine to 1.5 mg/dL, suggesting worsening kidney function. The lipid panel remains largely unchanged, with LDL cholesterol at 158 mg/dL and HDL at 34 mg/dL. Urinalysis now shows a higher level of microalbuminuria, further signaling the progression of nephropathy. Additionally, the patient's liver function tests come back slightly abnormal, raising concerns about potential drug-induced hepatotoxicity or non-alcoholic fatty liver disease, which may necessitate re-evaluation of his medication regimen.

The healthcare team deliberates on the next steps, recognizing the importance of addressing both the patient's adherence issues and the potential side effects of his current medications. A plan is made to switch his antihypertensive agent to one less likely to cause orthostatic hypotension and to consider the addition of a new antihyperglycemic agent that may also offer renal protective benefits. The patient is counseled on the importance of adequate hydration and the timing of medication intake relative to meals and activity levels. The team schedules regular follow-ups to closely monitor his response to these adjustments, with the goal of preventing further complications and improving his overall quality of life.

Section 4

Two weeks later, the patient returns for a follow-up visit, and this time, there is a noticeable improvement in some of his symptoms, though new challenges have emerged. He reports that the episodes of dizziness have reduced significantly since the change in his antihypertensive medication, suggesting the adjustment was beneficial in managing his orthostatic hypotension. However, he still experiences occasional swelling in his legs, particularly after long periods of standing at work. His blood pressure readings are more stable, showing 138/88 mmHg when sitting and 130/85 mmHg upon standing, indicating a more consistent blood pressure control.

Despite these improvements, the patient expresses concern about new symptoms of fatigue and a persistent dull ache in his lower back. Repeat laboratory tests reveal a serum creatinine level of 1.6 mg/dL, indicating further deterioration in kidney function. Additionally, his HbA1c has not improved, remaining at 9.0%, underscoring persistent challenges in achieving better glycemic control. Urinalysis continues to show elevated microalbuminuria, and new findings suggest the presence of trace amounts of proteinuria, signaling potential progression towards more significant nephropathy.

The healthcare team recognizes that while the adjustment in antihypertensive therapy has helped with the orthostatic symptoms, there is a pressing need to address the ongoing renal issues and glycemic control. They consider introducing a Sodium-glucose co-transporter-2 (SGLT2) inhibitor, an antihyperglycemic agent known for its renal protective benefits, which might also aid in managing the patient's blood sugar levels. The team continues to emphasize lifestyle modifications, including dietary adjustments and exercise, to support these pharmacological interventions. They schedule more frequent follow-ups to closely monitor the patient's renal function, glycemic levels, and overall response to the new treatment strategy, aiming to prevent further decline and improve his quality of life.

Section 5

Three weeks after the introduction of the Sodium-glucose co-transporter-2 (SGLT2) inhibitor, the patient returns for another follow-up appointment. Upon initial assessment, the healthcare team notes a reduction in his fasting blood glucose levels, now averaging around 150 mg/dL, a sign that the SGLT2 inhibitor is contributing to improved glycemic control. Additionally, the patient's weight has decreased slightly, which is a positive outcome considering his previous concerns about obesity. His blood pressure remains stable, with readings of 134/82 mmHg while sitting and 128/80 mmHg upon standing, reflecting ongoing benefits from the adjusted antihypertensive regimen.

However, the patient reports experiencing increased urinary frequency and mild dehydration symptoms, such as dry mouth and lightheadedness upon standing, which are potential side effects of the new medication. The healthcare team considers these symptoms and evaluates his fluid intake, encouraging the patient to maintain adequate hydration, particularly given the diuretic effect of the SGLT2 inhibitor. They also advise monitoring for any signs of urinary tract infections, as increased urination can sometimes predispose individuals to such complications.

Laboratory results reveal a slight improvement in renal function, with serum creatinine now at 1.5 mg/dL, suggesting a minimal but encouraging response in slowing kidney deterioration. However, urinalysis still shows elevated microalbuminuria, with proteinuria levels remaining unchanged, indicating that while some aspects of his renal health are stabilizing, vigilance remains crucial. The team decides to continue with the current treatment plan but emphasizes the importance of ongoing lifestyle modifications and regular monitoring. They plan to reassess the patient's condition in a month, with a focus on preventing dehydration, managing blood sugar levels, and closely tracking renal function to preempt any further complications.